Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MO › Saint Louis › NPI 1649299827
Hospital

Barnes Jewish Hospital

Barnes Jewish Hospital was paid $61.34M by Medicaid between Jan 2018 and Dec 2024, across 245 billing codes. Its largest line is X4011, State-specific procedure code — 22% of everything it billed.

33Billing provider infoBARNES JEWISH HOSPITAL
SAINT LOUIS, MO 63110
33aNPI1649299827assigned 07/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$61.34M
24GClaims794,879
24DCodes billed245
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Missouri

Rank by total paid#3 of 74
Median peer was paid$4.44M
This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018105,980$15.15M
2019106,222$12.91M
202097,875$8.37M
2021108,692$4.21M
2022133,630$7.03M
2023138,112$8.02M
2024incomplete104,368$5.66M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
X4011 State-specific procedure code 22% 28,126 26,546 $13.44M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 13% 102,268 93,754 $7.68M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.3% 17,314 16,338 $5.71M
X4003 4.5% 47,475 42,909 $2.78M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 3.9% 15,591 14,544 $2.38M
81002 3.2% 31,827 25,101 $1.99M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.9% 73,408 67,758 $1.79M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 2.2% 7,002 6,607 $1.36M
X4006 1.9% 1,372 1,143 $1.17M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.5% 16,922 15,656 $916K
86900 1.4% 9,300 8,443 $847K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.3% 12,048 11,611 $792K
233 more codes
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.3% 12,051 $778K
59025 Fetal non-stress test 1.2% 3,675 $764K
80053 Comprehensive metabolic panel 1.2% 45,541 $756K
85027 1.2% 13,231 $737K
86850 1.2% 9,283 $732K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.1% 4,500 $682K
86901 1.1% 9,291 $681K
81025 <1% 9,473 $593K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 3,534 $555K
86592 <1% 12,752 $548K
J2426 Injection, paliperidone palmitate extended release (invega sustenna), 1 mg <1% 853 $534K
80048 Basic metabolic panel (calcium, ionized) <1% 18,151 $512K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 4,454 $512K
77067 Screening mammography, bilateral, including computer-aided detection <1% 5,109 $499K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,785 $455K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 11,214 $452K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,278 $415K
Y7506 <1% 1,160 $400K
J3490 Unclassified drugs <1% 8,378 $399K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,166 $351K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 5,571 $334K
G0378 Hospital observation service, per hour <1% 3,254 $331K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 9,182 $325K
71046 Radiologic examination, chest; 2 views <1% 6,762 $323K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 2,832 $294K
86787 <1% 3,766 $291K
76819 Fetal biophysical profile; without non-stress testing <1% 1,780 $269K
Y7507 <1% 1,278 $256K
88142 <1% 2,453 $243K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 1,296 $238K
83020 <1% 3,454 $234K
81001 <1% 8,064 $229K
87340 <1% 3,845 $223K
36415 Collection of venous blood by venipuncture <1% 11,900 $221K
86762 <1% 3,209 $208K
86803 <1% 3,424 $196K
83036 Hemoglobin; glycosylated (A1C) <1% 20,514 $188K
77063 Screening digital breast tomosynthesis, bilateral <1% 5,036 $188K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 921 $185K
87536 <1% 2,117 $171K
87081 <1% 2,004 $164K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,295 $162K
82950 <1% 3,009 $158K
84484 <1% 8,396 $156K
76801 <1% 1,262 $140K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,289 $138K
P9016 Red blood cells, leukocytes reduced, each unit <1% 491 $130K
87077 <1% 1,991 $130K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,453 $121K
84443 Thyroid stimulating hormone (TSH) <1% 6,258 $116K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 570 $115K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 5,427 $111K
80061 Lipid panel <1% 7,413 $105K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 2,686 $94K
G0475 Hiv antigen/antibody, combination assay, screening <1% 4,890 $89K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,125 $85K
76820 <1% 478 $83K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 912 $81K
84156 <1% 2,093 $81K
82962 <1% 5,778 $79K
82728 <1% 2,839 $78K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,461 $77K
82570 <1% 5,363 $77K
90870 <1% 449 $73K
70450 Computed tomography, head or brain; without contrast material <1% 1,133 $71K
80081 <1% 307 $64K
86920 <1% 483 $57K
86922 <1% 500 $57K
36430 <1% 405 $56K
76830 Ultrasound, transvaginal <1% 494 $56K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,981 $54K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 156 $54K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,368 $53K
Y7510 <1% 75 $48K
86361 <1% 1,046 $47K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 41 $38K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 698 $37K
71045 Radiologic examination, chest; single view <1% 1,074 $37K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 387 $35K
73630 <1% 802 $34K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 318 $33K
99213 Doctor's office visit, returning patient (routine) <1% 565 $31K
96375 Therapeutic injection; each additional sequential IV push <1% 1,297 $30K
73610 <1% 588 $26K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 396 $26K
Q3014 Telehealth originating site facility fee <1% 1,948 $24K
85610 <1% 5,713 $24K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,238 $22K
90480 <1% 1,072 $21K
73030 <1% 631 $20K
73564 <1% 497 $19K
0054A <1% 676 $19K
87631 <1% 138 $18K
81003 <1% 7,041 $18K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 99 $18K
83550 <1% 1,862 $18K
0124A <1% 673 $17K
82607 <1% 1,345 $17K
83540 <1% 2,032 $16K
83690 <1% 1,371 $16K
82043 <1% 3,086 $14K
81511 <1% 78 $13K
72125 Computed tomography, cervical spine; without contrast material <1% 174 $11K
J1631 Injection, haloperidol decanoate, per 50 mg <1% 1,794 $11K
96361 Intravenous infusion, hydration; each additional hour <1% 442 $10K
83880 <1% 375 $10K
84439 <1% 961 $9K
86902 <1% 121 $9K
73130 <1% 168 $9K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 61 $9K
83735 <1% 1,714 $8K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 157 $8K
83605 <1% 594 $8K
82077 <1% 618 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 14 $7K
87184 <1% 232 $7K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 49 $7K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 1,513 $6K
90732 <1% 122 $6K
P3000 Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision <1% 95 $6K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 124 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 109 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 61 $5K
73552 <1% 117 $5K
36591 <1% 75 $5K
0004A <1% 144 $5K
86481 <1% 57 $5K
72100 <1% 67 $4K
84702 <1% 166 $4K
90715 <1% 134 $4K
20610 <1% 26 $4K
73590 <1% 67 $4K
84550 <1% 148 $4K
86706 <1% 393 $4K
85660 <1% 613 $4K
85730 <1% 419 $4K
87040 <1% 189 $3K
82746 <1% 163 $3K
86704 <1% 248 $3K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 16 $3K
73560 <1% 28 $3K
99460 <1% 32 $3K
0052A <1% 84 $3K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 64 $3K
0051A <1% 74 $2K
71250 <1% 26 $2K
82248 <1% 198 $2K
82803 <1% 104 $2K
0002A <1% 55 $2K
62323 <1% 13 $2K
72082 <1% 26 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 222 $1K
0001A <1% 38 $1K
0053A <1% 36 $1K
31575 <1% 68 $1K
73562 <1% 29 $1K
85652 <1% 350 $948.79
88313 <1% 18 $925.69
72170 <1% 13 $893.35
J3370 Injection, vancomycin hcl, 500 mg <1% 87 $876.69
86140 <1% 288 $833.18
80197 <1% 207 $796.81
83615 <1% 489 $771.98
80050 General health panel <1% 29 $757.49
77066 Tomosynthesis, mammo <1% 13 $708.36
88307 <1% 12 $588.64
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 142 $514.59
77001 <1% 14 $479.22
80076 <1% 48 $463.39
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 18 $463.11
J2704 Injection, propofol, 10 mg <1% 32 $450.36
82784 <1% 58 $449.61
0121A <1% 30 $427.37
82010 <1% 64 $412.51
87210 <1% 12 $409.64
84100 <1% 140 $392.01
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 32 $384.00
87497 <1% 23 $380.70
86038 <1% 31 $363.40
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 229 $332.00
J1644 Injection, heparin sodium, per 1000 units <1% 48 $319.71
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 218 $300.30
87522 Neg quan hep c or qual rna <1% 12 $298.64
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 56 $294.15
80069 <1% 50 $292.08
82330 <1% 14 $283.50
90677 <1% 149 $275.08
J0692 Injection, cefepime hydrochloride, 500 mg <1% 27 $251.34
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 31 $238.66
84403 <1% 28 $232.30
84146 <1% 14 $219.85
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 60 $204.87
G0008 Administration of influenza virus vaccine <1% 1,056 $204.13
87070 <1% 43 $193.03
58100 <1% 12 $173.39
86160 <1% 16 $171.76
84153 <1% 28 $165.50
83883 <1% 22 $165.48
83970 <1% 15 $165.10
84165 <1% 29 $161.24
J0690 Injection, cefazolin sodium, 500 mg <1% 37 $148.18
82378 <1% 15 $148.08
83521 <1% 15 $129.05
91320 <1% 425 $124.15
87205 <1% 30 $119.59
82105 <1% 14 $105.02
76937 <1% 17 $103.55
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 162 $102.80
90662 <1% 597 $92.88
J7140 <1% 13 $87.50
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 25 $68.88
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 14 $55.50
86923 <1% 35 $50.83
J2060 Injection, lorazepam, 2 mg <1% 12 $41.86
J1940 Injection, furosemide, up to 20 mg <1% 14 $39.87
90686 <1% 710 $17.75
82951 <1% 12 $10.29
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 12 $0.45
J0697 Injection, sterile cefuroxime sodium, per 750 mg <1% 12 $0.05
96376 0% 492 $0.00
G0009 Administration of pneumococcal vaccine 0% 207 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 59 $0.00
90656 0% 87 $0.00
93320 0% 12 $0.00
51798 0% 14 $0.00
0000 0% 17 $0.00
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 0% 39 $0.00
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 0% 31 $0.00
V2632 Posterior chamber intraocular lens 0% 13 $0.00
93325 0% 12 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 12 $0.00
90472 Immunization administration, each additional vaccine (list separately) 0% 17 $0.00
92504 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialIROVIC, PAUL (VICE PRESIDENT)
Same official

Other billing entities under IROVIC, PAUL

Full network →
ProviderLocationPaid
Christian Hospital Northeast- NorthwestSaint Louis, MO$65.26M
Barnes Jewish HospitalSaint Louis, MO$56K
Barnes Jewish HospitalSaint Louis, MO$20K
Barnes Jewish HospitalSaint Louis, MO$12K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.